TOR Complex 2 and sphingolipid biosynthesis.

TOR 复合物 2 和鞘脂生物合成。

• 批准号: 8089533
• 负责人: TED POWERS
• 金额: $ 30.45万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2013-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8089533
• 关键词: Address; Affect; Aging; Anabolism; Apoptosis; Area; Biochemical; Biological Models; Biomedical Research; Catabolism; Cell Culture Techniques; Cell Proliferation; Cells; Ceramides; Complex; Disease; Drug effect disorder; Enzymes; Equilibrium; Eukaryota; Eukaryotic Cell; Family; Genetic; Goals; Health; Human; Investigation; Laboratories; Link; Lipids; Malignant Neoplasms; Mammalian Cell; Mediating; Metabolism; Molecular; Mutation; Orthologous Gene; Pathway interactions; Pharmaceutical Preparations; Phosphotransferases; Physiological; Play; Process; Production; Proliferating; Property; Protein Isoforms; Protein-Serine-Threonine Kinases; Regulation; Relative (related person); Role; Saccharomycetales; Set protein; Signal Pathway; Signal Transduction; Sirolimus; Sphingolipids; Stress; System; Therapeutic; Time; Work; Yeasts; base; cancer cell; cancer therapy; cell growth; cell killing; cell transformation; dihydroceramide desaturase; enzyme activity; in vitro activity; in vivo; insight; interest; long chain fatty acid; member; neoplastic cell; novel; protein complex; research study; response; tumorigenesis

DESCRIPTION (provided by applicant): Our long-term goal is to understand the molecular mechanisms by which cell growth is controlled in eukaryotic cells, in particular by the rapamycin-sensitive TOR kinase. Recent studies in several laboratories, including my own, have demonstrated that TOR functions as part of two distinct protein complexes, TORC1 and TORC2, where TORC1 is uniquely inhibited by rapamycin. Rapamycin is proving to have many beneficial therapeutic applications, including as a potential anti-cancer treatment, and so there is great interest in understanding more about the cellular role of TOR. Because it is not a direct target for rapamycin, however, the cellular role of TORC2 has remained much less well characterized than TORC1. Accordingly, alternative approaches are needed to study TORC2. To this end, we have discovered recently that a mutation within a TORC2-specific component affects dramatically the earliest steps of the sphingolipid pathway, in particular the de novo formation of ceramides, in budding yeast. More recently, we have extended this observation to mammalian cells, where we have shown that inhibiting mTORC2 function in HEK393T cells also leads to a reduction in the activity of the enzyme ceramide synthase. Ceramides, as well as their immediate precursors, the fatty acid long chain bases (LCBs), represent classes of lipids that are increasingly recognized as playing crucial roles in malignant cell growth, tumorigenesis, as well as aging. Thus, both TOR and ceramide biosynthesis represent important areas important for biomedical research, and our findings indicate for the first time that they are intimately linked. In the experiments proposed here, we will identify the mechanism by which ceramide synthesis is regulated by TORC2, including a detailed analysis of the ceramide synthase, and will begin to delineate the signaling pathway involved in this regulation. For this purpose, we will use both yeast and mammalian cells as complementary experimental systems. We will also address the role that mTORC2 signaling plays in the response of certain cancer cells to chemotherapeutic drugs, which are known to increase the de novo synthesis of ceramides and contribute to the cell killing action of these drugs by inducing ceramide-mediated apoptosis. PUBLIC HEALTH RELEVANCE: The proposed experiments address the role of a highly conserved signaling pathway, defined by the TOR kinase, in the regulation of synthesis of precursors to complex sphingolipids, in particular ceramides, using both yeast and mammalian cell culture. Both TOR signaling and ceramides are known to play important roles in cell proliferation, stress, cancer, as well as aging. Thus, our work brings together these two areas of investigation that are very important for understanding human health and disease and we expect to gain novel insights into these processes through our studies.

描述（由申请人提供）：我们的长期目标是了解真核细胞中控制细胞生长的分子机制，特别是雷帕霉素敏感性TOR激酶。包括我自己在内的几个实验室最近的研究表明，TOR作为两种不同的蛋白质复合物TORC 1和TORC 2的一部分发挥作用，其中TORC 1被雷帕霉素独特地抑制。雷帕霉素被证明具有许多有益的治疗应用，包括作为潜在的抗癌治疗，因此人们对更多地了解TOR的细胞作用非常感兴趣。然而，由于它不是雷帕霉素的直接靶点，TORC 2的细胞作用仍然不如TORC 1那么好表征。因此，需要替代方法来研究TORC 2。为此，我们最近发现，TORC 2特异性组分内的突变显著影响了鞘脂途径的最早步骤，特别是芽殖酵母中神经酰胺的从头形成。最近，我们将这一观察结果扩展到哺乳动物细胞，我们已经表明，抑制HEK393T细胞中的mTORC 2功能也会导致神经酰胺合酶活性的降低。神经酰胺及其直接前体脂肪酸长链碱基（LCB）代表了越来越多地被认为在恶性细胞生长，肿瘤发生以及衰老中发挥关键作用的脂质类。因此，TOR和神经酰胺生物合成都代表了生物医学研究的重要领域，我们的研究结果首次表明它们是密切相关的。在这里提出的实验中，我们将确定神经酰胺合成受TORC 2调节的机制，包括对神经酰胺合酶的详细分析，并将开始描绘参与这种调节的信号通路。为此，我们将使用酵母和哺乳动物细胞作为互补的实验系统。我们还将讨论mTORC2信号在某些癌细胞对化疗药物的反应中所起的作用，已知化疗药物可增加神经酰胺的从头合成，并通过诱导神经酰胺介导的细胞凋亡促进这些药物的细胞杀伤作用。公共卫生关系：所提出的实验解决了高度保守的信号传导途径的作用，定义的TOR激酶，在调节合成的前体复杂的鞘脂，特别是神经酰胺，使用酵母和哺乳动物细胞培养。已知TOR信号传导和神经酰胺在细胞增殖、应激、癌症以及衰老中发挥重要作用。因此，我们的工作汇集了这两个对了解人类健康和疾病非常重要的调查领域，我们希望通过我们的研究获得对这些过程的新见解。